We have generated transgenic mice that express green fluorescent protein (GFP) under the control of the mouse insulin I gene promoter (MIP). The MIP-GFP mice develop normally and are indistinguishable from control animals with respect to glucose tolerance and pancreatic insulin content. Histological studies showed that the MIP-GFP mice had normal islet architecture with co-expression of insulin and GFP in the β-cells of all islets. We observed GFP expression in islets from embryonic E13.5 day through adult. Studies of β-cell function revealed no difference in glucose-induced intracellular calcium mobilization between islets from transgenic and control animals. We prepared single-cell suspensions from both isolated islets and whole pancreas from MIP-GFP transgenic mice and sorted the β-cells by fluorescence-activated cell sorting based on their green fluorescence. These studies showed that 2.4±0.2% (n=6) of the cells in the pancreas of newborn (P1) and 0.9±0.1% (n=5) of 8-week old mice were β-cells. The MIP-GFP transgenic mice may be a useful tool for studying β-cell biology in normal and diabetic animals.
INTRODUCTION
The insulin-producing β-cell of the pancreas plays a central role in the pathophysiology of diabetes mellitus with anatomical and functional loss of these cells leading to type 1 and type 2 diabetes mellitus, respectively (1) . The identification and characterization of embryonic or adult stem cells that give rise to the β-cell could lead to cellular-based therapies for treating both forms of diabetes (2) (3) (4) . Previous studies have shown that green fluorescent protein (GFP) from the jellyfish Aequorea victoria and its yellow and cyan derivatives could be utilized as reporter genes to label specific cell types including pancreatic β-cells by expressing GFP under the control of a tissue-specific promoter (5) (6) (7) (8) (9) (10) (11) (12) . One advantage of these proteins is that they can be detected in living cells since they fluoresce brightly upon exposure to ultraviolet light or blue light without the addition of coactivators or exogenous substrate. In addition, pure populations of fluorescent-tagged cells can be isolated using a fluorescence-activated cell sorter (FACS) (9, 10, 12) . Studies of rat and human β-cells treated with recombinant adenovirus expressing green fluorescent protein (GFP) under the control of the rat insulin I promoter appear to function normally suggesting expression of GFP may be well-tolerated by these cells (11, 12) . Thus, we reasoned that if we could generate a mouse model in which we had genetically tagged the pancreatic β-cells with GFP, we would have a potentially valuable research tool for studying β-cell biology including the identification of progenitor cells. Here, we describe a line of transgenic mice in which the pancreatic β-cells are genetically tagged with GFP.
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MATERIALS AND METHODS
Generation of MIP-GFP transgenic mice. The mouse insulin I (MIP) promoter-GFP transgenic
construct was assembled using a 8.5 kb fragment of the mouse insulin I promoter that includes a region from -8.5 kb to +12 bp (relative to the transcriptional start site), the coding region of enhanced GFP (EGFP) (0.76 kb) (Clontech, Palo Alto, CA), and a 2.1 kb fragment of the human growth hormone cassette gene (hGH) for high-level expression (13, 14) . The 11.2 kb MIP-EGFP-hGH fragment was isolated from the vector by digestion of the plasmid construct with Sfi I and Hind III and agarose gel electrophoresis. The fragment was further purified using an Glucose tolerance testing. Intraperitoneal glucose tolerance tests (IPGTTs) were performed after a 4-h fast. Blood was sampled from the tail vein before and 30, 60, 90 and 120 min after intraperitoneal injection of 2 mg/g (body weight) of dextrose. Glucose levels were measured using a Precision Q.I.D.
TM Glucometer (MediSense, Waltham, MA).
Insulin assays. Pancreatic insulin content was measured after acid ethanol extraction of the whole pancreas as described previously (15) . Insulin concentration was measured by a doubleantibody radioimmunoassay using a rat insulin standard in the Radioimmunoassay Core
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Laboratory of the University of Chicago DRTC. The intraassay coefficient of variation for this assay is 7%. All samples were assayed in duplicate.
Isolation of pancreatic islets of Langerhans. Pancreatic islets were isolated using a modification of the procedure originally described by Lacy and Kostianovsky (16) . Briefly, the pancreas was inflated with a solution containing 0.3 mg/ml collagenase (Type XI; Sigma, St.
Louis, MO) in Hanks' balanced salt solution, injected via the pancreatic duct. The inflated pancreas was removed, incubated at 37°C for 10 min, and shaken vigorously to disrupt the tissue. Following differential centrifugation through a Ficoll gradient to separate islets from acinar tissue, the islets were washed and then handpicked. They were plated on 12-or 35-mm coverslips to facilitate adherence for subsequent measurement of intracellular calcium or confocal microscopic visualization. The islets were cultured in RPMI 1640 supplemented with 10% (vol/vol) fetal bovine serum (FBS), 100 U/ml penicillin and 100 µg/ml streptomycin in a humidified incubator at 37°C in 95% air and 5% CO 2 .
Preparation of single-cell suspensions from islets and pancreas. Isolated islets were incubated in a solution of 0.05% trypsin-EDTA (GIBCO, Grand Island, NY) at 37°C for 3 min. 
Intracellular calcium measurements.
The GFP expression interferes with Fura-2 signals and as a consequence the calcium indicator Fura-2 cannot be used to monitor changes in intracellular calcium in GFP-expressing β-cells. The short wavelength excitation of the EGFP excitation spectrum extends down to ~350 nm which is in the range of Fura-2. Thus, excitation of Fura-2 will excite EGFP and contaminate the common emission spectrum. Fura Red is a calcium indicator with a large stokes shift, thereby minimizing the contamination of the calcium signal by GFP (18, 19) . Fura Red has been successfully used in combination with GFP expression in other studies (20, 21) ; however, there are reports of some signal crosstalk when used with EGFP (22).
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Another calcium indicator, X-rhod-1 which has an excitation/emission maxima of ~580/ 602 nm may also give a good separation of the signals from GFP and the calcium indicator (22); however, care must be taken, since X-rhod-1 has a certain selectivity for mitochondria (23) . We used Fura Red in the studies described here. The isolated islets were loaded with 5 µmol/l Fura Red-AM (acetoxymethyl ester) (Molecular Probes, Eugene, OR) and changes in intracellular calcium were monitored using a Fluoview scanning laser confocal with an inverted IX70 microscope (Olympus). Tiempo real-time acquisition software (Olympus) was used to collect and plot the data. The Cy5 filter set (700/75 nm bandpass filter set) was used to detect Fura Red signals and to eliminate the contamination with GFP signals. Solutions were perfused in a temperature-controlled chamber using a TC-344 Dual Heater Controller (Warner Instrument
Corp., Hamden, CT). All the measurements were performed at 34-35°C.
Flow cytometric analysis.
Flow cytometric analysis of GFP-labeled β-cells was carried out using a FACScan flow cytometer with Cell Quest software (Becton Dickinson, Franklin Lakes, NJ). GFP-expressing cells were detected using the FL1 channel (absorption spectra 530/30 nm).
We have sorted both fixed and non-fixed cells. However, the studies described here were carried out using cells fixed as described above.
Statistical analysis.
Results are expressed as mean ± SEM. We compared groups using Anova (StatView software, SAS Institute Inc., Cary, NC). Differences were considered to be significant at P< 0.05. The pancreatic islets from the MIP-GFP transgenic animals were green when exposed to ultraviolet light (Fig. 1A) . The overall islet architecture of the MIP-GFP mice was normal. The patterns of GFP and insulin expression within the islet were identical and GFP expression was only observed in β-cells (Fig. 1) . There was no evidence of expression of GFP in non-β-cells of the islet or in the exocrine pancreas (Fig. 1D) . A stacked confocal microscopic image of an isolated islet suggested that the steady state levels of GFP were similar in all β-cells (Fig. 1E) .
We also tested for expression of GFP in the pancreas and other tissues at 6-wk of age by Western blotting. We detected GFP expression only in pancreas and not in any of the other tissues examined: brain, fat, muscle, small intestine, spleen, heart, kidney, liver, uterus and testis (data not shown). In addition, we also examined sections from each of these tissues for the presence of isolated GFP-expressing cells and found none. The transgene construct includes the human growth hormone gene at its 3'-end since previous studies have shown that the presence of 9 heterologous introns provided by the human growth hormone gene resulted in enhanced expression of the transgene (13). Since there is no internal ribosomal entry site upstream of the growth hormone gene, there should be no growth hormone expression and as expected, we found no evidence of growth hormone in islets from MIP-GFP mice by immunohistochemical staining using sections from pituitary as a positive control (data not shown). Expression of the MIP-GFP transgene appears to be restricted to β-cells. The mouse insulin I promoter fragment that we used appears to be more tissue-specific in its expression than shorter fragments (that are more typically used to make insulin promoter driven fusion genes), since no expression was observed in brain using this construct whereas expression in the brain is often observed with the shorter promoter construct (14) .
Physiological characterization of MIP-GFP mice.
The MIP-GFP mice developed normally. At 6-wk of age, there were no significant differences in body weight, fasting blood glucose and pancreatic insulin content between transgenic and nontransgenic CD-1 male mice (data not shown). Intraperitoneal glucose tolerance testing (IPGTT) at 6-wk showed no statistically significant difference in the response between transgenic and nontransgenic male animals ( Fig. 2). We have followed body weight and performed IPGTTs on the transgenic mice up to 40-wk, body weight and non-fasting blood glucose levels up to 60-wk and none of the animals have shown any evidence of abnormal weight or hypo-or hyperglycemia (data not shown.)
Glucose responsiveness of pancreatic islets from the MIP-GFP mice. We examined the effects of glucose on intracellular calcium mobilization in the islets of the MIP-GFP mice as a measure of β-cell function. We used Fura Red (24) to monitor intracellular calcium levels to allow measurement of signals from the calcium indicator in the presence of GFP. The islets from both MIP-GFP and nontransgenic mice exhibited a robust mobilization of calcium in response to 10 10 mM glucose with no apparent difference between the islets from transgenic and nontransgenic animals ( Fig. 3) . Similar responses were observed in response to 20 mM glucose and 50 mM KCl occasionally accompanied by oscillations in calcium levels (data not shown).
FACS analysis of GFP-labeled -cells.
The islets isolated from MIP-GFP mice (8-wk old) were dissociated into single cells. The GFP-labeled β-cells could be readily separated from the non-β-cells cells by FACS (Fig. 4 shows a representative trace) .
Measurement of pancreatic -cell number.
A single-cell suspension was prepared from whole pancreas of a MIP-GFP transgenic mouse at P1 (Fig. 5A) 
Expression of MIP-GFP transgene during development.
The pancreas begins to form at the 26 somite stage (E9.5) of gestation in the mouse (25) . Although insulin mRNA can be detected at the 20-somite stage (25), significant expression of insulin only begins at E13.5 (26) . We observed GFP-labeled cells in the pancreas at E13.5 (we did not examine earlier stages) and continuing throughout life. At E13.5, there is a scattered mass of GFP-expressing cells in the pancreas adjacent to the duodenum. GFP-labeled islets are evident at E18.5 and in the adult (60-wk) where they can be readily seen distributed throughout the pancreas.
DISCUSSION
We have generated transgenic mice in which pancreatic β-cells are genetically tagged with GFP. The phenotypic characterization of the MIP-GFP transgenic mice suggests that the presence of cytoplasmic GFP does not impair β-cell development or function, at least in the line of mice described in this report. We can envisage a number of uses of these mice for studying β-cells in situ and in isolation. In this regard, β-cell function can be studied in the MIP-GFP mice or in intercrosses with other genetically engineered and mutant mice. We believe the MIP-GFP mice will be useful for isolating pancreatic β-cells at various stages of development from embryonic to adult. The purified β-cells can be used for molecular biological studies such as monitoring the changing pattern of gene expression during development using microarrays (27) or for biophysical studies of their functional properties (28) . The isolation of a pure population of β-cells is arduous. Pipeleers and his colleagues have described a procedure that works well with rat islets beginning with purified islets (29) . The islets are dissociated into single cells from We also believe that we may be able to use FACS analysis to monitor changes in β-cell size. Finally, the GFP fluorescence is sufficiently intense, especially in the adult, to be detected within a thick specimen including a whole pancreas (Fig. 5) . Thus, it may be possible to carry out a 3-dimensional reconstruction of the distribution of islets within the entire pancreas of the MIP-GFP mice.
In summary, we have generated a line of mice in which the β-cells are genetically tagged with GFP. We believe that the MIP-GFP mice will be a useful tool for studying β-cells and islets in normal and diabetic states. 
